NAS:HALO (USA)
Business Description
Halozyme Therapeutics Inc
NAICS : 325414
SIC : 2836
11388 Sorrento Valley Road, San Diego, CA, USA, 92121
Compare
Compare
Traded in other countries / regions
RV7.Germany
•
HALO.Mexico
•
0J2O.UK
•
HALO.USA
Description
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 4.25 | |||||
| Debt-to-EBITDA | 4.85 | |||||
| Interest Coverage | 27.89 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.38 | |||||
| Beneish M-Score | 14.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.9 | |||||
| 3-Year Book Growth Rate | -5.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 11.81 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.01 | |||||
| 9-Day RSI | 34.92 | |||||
| 14-Day RSI | 38.36 | |||||
| 6-1 Month Momentum % | 48.88 | |||||
| 12-1 Month Momentum % | 20.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 1.05 | |||||
| Days Inventory | 254.42 | |||||
| Days Sales Outstanding | 94.64 | |||||
| Days Payable | 18.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.7 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.53 | |||||
| Operating Margin % | 49.61 | |||||
| Net Margin % | 75.11 | |||||
| ROE % | 158.95 | |||||
| ROA % | 29.25 | |||||
| ROIC % | 68.67 | |||||
| ROC (Joel Greenblatt) % | 119.37 | |||||
| ROCE % | 21.59 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.89 | |||||
| PE Ratio without NRI | 16.89 | |||||
| Shiller PE Ratio | 697.04 | |||||
| Price-to-Owner-Earnings | 14.49 | |||||
| PS Ratio | 12.58 | |||||
| PB Ratio | 20.07 | |||||
| Price-to-Free-Cash-Flow | 21.27 | |||||
| Price-to-Operating-Cash-Flow | 21.13 | |||||
| EV-to-EBIT | 28.62 | |||||
| EV-to-EBITDA | 26.96 | |||||
| EV-to-Revenue | 14.2 | |||||
| EV-to-Forward-Revenue | 11.82 | |||||
| EV-to-FCF | 24.19 | |||||
| Price-to-Projected-FCF | 5.34 | |||||
| Price-to-Median-PS-Value | 0.84 | |||||
| Earnings Yield (Greenblatt) % | 3.5 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:HALO
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 487.477 | ||
| EPS (TTM) ($) | 2.53 | ||
| Beta | 1.19 | ||
| Volatility % | 39.34 | ||
| 14-Day RSI | 38.36 | ||
| 14-Day ATR ($) | 1.962842 | ||
| 20-Day SMA ($) | 46.8305 | ||
| 12-1 Month Momentum % | 20.73 | ||
| 52-Week Range ($) | 31.36 - 52.98 | ||
| Shares Outstanding (Mil) | 137.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Halozyme Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||